Be sure to read the Qrtly Report thoroughly as it covers a lot. Small company with little Revs, but seems to have a lot of promise.
As a side note, the company has won approval for the human use of Hemopure in Africa. They are currently in PhaseII and PhaseIII trials and seem to be getting a fast track status via the Military. The stock offering caused a dip in price although it is my understanding (I cannot seem to find the link now) that the CEO, CFO & COO (or something like that) purchased 930,000 shares from this recent offering and the stock has been going back up ever since. Then on Friday it got a big jump in AH although I am not sure why.
As always, this is not a solicitation to buy. Do DD and be careful out there...